Deadline: Ongoing
The MSWA Multiple Sclerosis & Neurological Care Accelerator 2026 is a specialised global programme designed to support early-stage ventures building innovative solutions for neurological conditions. This accelerator provides founders with the opportunity to scale impactful technologies that address real needs in neurological care. Through expert-led venture support, direct investment, and access to leading clinicians and industry networks, the programme empowers innovators to create solutions that improve the lives of people affected by multiple sclerosis and related neurological conditions.
About the Opportunity
The MSWA Multiple Sclerosis & Neurological Care Accelerator 2026 is tailored for startups working on technologies that advance understanding, treatment, recovery, and day-to-day management of neurological health conditions. These include multiple sclerosis (MS), stroke, Parkinson’s disease, Huntington’s disease, motor neurone disease, and acquired brain injury.
The programme supports innovations across a wide spectrum of deep-tech and health-tech categories, such as AI-driven clinical tools, robotics for mobility, digital health platforms, wearable technologies, and frontier scientific breakthroughs. Solutions that address the unique needs of First Nations populations are also welcomed.
This accelerator offers a strategic route for startups seeking to commercialise their products, access expert guidance, and collaborate with influential partners across the neurological and healthcare ecosystems.
Eligibility
To qualify for the programme, applicants must:
- Operate as early-stage or growth-focused ventures developing solutions for neurological care.
- Work on innovations that may include AI, robotics, digital health, scientific research applications, or wearable technologies.
- Address at least one neurological condition such as MS, Parkinson’s disease, stroke, Huntington’s disease, acquired brain injury, or motor neurone disease.
- Be based in Australia.
Benefits / Award Details
Selected startups receive extensive support designed to accelerate product development, market readiness, and long-term commercial growth. Benefits include:
- Cash investment and potential access to future funding rounds through the accelerator’s investor network.
- A structured venture-building programme delivered over approximately four months (16 weeks), offering support across product development, operations, commercialisation, data science, partnerships, and fundraising.
- Access to a global network of clinicians, researchers, health-tech experts, investors, and fellow founders.
- Commercial opportunities including potential pilot programmes and collaborations with MSWA and sector partners.
- Software, tools, and service credits valued at up to AUD 500,000 to support technical development and operational growth.
Application Requirements / Documents
Applicants should be prepared to provide:
- A clear description of their solution, product, or prototype.
- Evidence of early traction, market need, or validation.
- Details about the founding team and technical capabilities.
- A roadmap for development and commercialisation.
- Any relevant clinical, scientific, or technical documentation supporting the innovation.
Timeline / Key Dates
Key programme dates are set around the 2026 accelerator cycle. Applicants are encouraged to apply early to allow adequate time for review and potential follow-up discussions.
How to Apply
Applications are submitted online through the accelerator’s official portal. Startups must provide full details of their innovation, intended impact, commercial strategy, and team background.
Selection Process
The selection process is highly competitive and involves:
- Initial screening of applications based on eligibility and innovation potential.
- Detailed technical and clinical review of proposed solutions.
- Interviews or pitching sessions with the accelerator team.
- Final selection based on impact potential, feasibility, and alignment with neurological care priorities.
Additional Information / Terms
The programme is designed to support early scalability and long-term commercial viability for neurological innovations. Startups accepted into the accelerator gain ongoing support, potential access to follow-on investment, and opportunities to connect with sector partners for product testing and market entry.
Host Organisation
The accelerator is supported by MSWA in partnership with leading health-tech venture-building organisations. The hosts bring together clinical expertise, investment capability, and global innovation networks to help founders commercialise breakthrough neurological solutions.
Contact us for proposal drafting, refining and review.
Apply Here: Apply Now
Read More About the Programme: Learn More
